1. Szatkowski L, McNeill A. Diverging trends in smoking
behaviors according to mental health status. Nicotine Tob
Res. 2015;17(3):356-60. doi: 10.1093/ntr/ntu173.
2. Dickerson F, Stallings CR, Origoni AE, Vaughan C, Khushalani
S, Schroeder J, et al. Cigarette smoking among persons with
schizophrenia or bipolar disorder in routine clinical settings,
1999-2011. Psychiatr Serv. 2013;64(1):44-50. doi: 10.1176/
appi.ps.201200143.
3. Patel KR, Cherian J, Gohil K, Atkinson D. Schizophrenia:
overview and treatment options. P T. 2014;39(9):638-45.
4. Dani JA, De Biasi M. Cellular mechanisms of nicotine
addiction. Pharmacol Biochem Behav. 2001;70(4):439-46.
doi: 10.1016/s0091-3057(01)00652-9.
5. Benowitz NL. Pharmacology of nicotine: addiction,
smoking-induced disease, and therapeutics. Annu Rev
Pharmacol Toxicol. 2009;49:57-71. doi: 10.1146/annurev.
pharmtox.48.113006.094742.
6. Fergusson DM, Goodwin RD, Horwood LJ. Major depression
and cigarette smoking: results of a 21-year longitudinal
study. Psychol Med. 2003;33(8):1357-67. doi: 10.1017/
s0033291703008596.
7. Mendelsohn C. Smoking and depression--a review. Aust Fam
Physician. 2012;41(5):304-7.
8. Novak G, Seeman P, Le Foll B. Exposure to nicotine produces
an increase in dopamine D2high receptors: a possible
mechanism for dopamine hypersensitivity. Int J Neurosci.
2010;120(11):691-7. doi: 10.3109/00207454.2010.513462.
9. Salmani N, Nozari M, Parvan M, Amini-Sardouei S, Shabani
M, Khaksari M, et al. Nicotine-conditioned place preference,
reversal learning and social interaction in MK-801-induced
schizophrenia model: effects of post-weaning enriched
environment. Clin Exp Pharmacol Physiol. 2022;49(8):871-
80. doi: 10.1111/1440-1681.13674.
10. Gubert C, Hannan AJ. Environmental enrichment as an
experience-dependent modulator of social plasticity and
cognition. Brain Res. 2019;1717:1-14. doi: 10.1016/j.
brainres.2019.03.033.
11. Rico-Barrio I, Peñasco S, Puente N, Ramos A, Fontaine CJ,
Reguero L, et al. Cognitive and neurobehavioral benefits of
an enriched environment on young adult mice after chronic
ethanol consumption during adolescence. Addict Biol.
2019;24(5):969-80. doi: 10.1111/adb.12667.
12. Lim AL, Taylor DA, Malone DT. Consequences of early
life MK-801 administration: long-term behavioural effects
and relevance to schizophrenia research. Behav Brain Res.
2012;227(1):276-86. doi: 10.1016/j.bbr.2011.10.052.
13. Faatehi M, Basiri M, Nezhadi A, Shabani M, Masoumi-Ardakani
Y, Soltani Z, et al. Early enriched environment prevents
cognitive impairment in an animal model of schizophrenia
induced by MK-801: role of hippocampal BDNF. Brain Res.
2019;1711:115-9. doi: 10.1016/j.brainres.2019.01.023.
14. Nozari M, Suzuki T, Rosa MG, Yamakawa K, Atapour N. The
impact of early environmental interventions on structural
plasticity of the axon initial segment in neocortex. Dev
Psychobiol. 2017;59(1):39-47. doi: 10.1002/dev.21453.
15. Haratizadeh S, Parvan M, Mohammadi S, Shabani M, Nozari
M. An overview of modeling and behavioral assessment of
autism in the rodent. Int J Dev Neurosci. 2021;81(3):221-8.
doi: 10.1002/jdn.10096.
16. Nazeri-Rezaabad M, Jamalpoor Z, Alemrajabi MS, Nozari M,
Razavinasab M, Nezhadi A. Chronic exposure to morphine
leads to a reduced affective pain response in the presence of
hyperalgesia in an animal model of empathy. Addict Health.
2020;12(4):251-8. doi: 10.22122/ahj.v12i4.280.
17. Haratizadeh S, Ranjbar M, Darvishzadeh-Mahani F, Basiri M,
Nozari M. The effects of postnatal erythropoietin and nanoerythropoietin on behavioral alterations by mediating K-Cl
co-transporter 2 in the valproic acid-induced rat model of
autism. Dev Psychobiol. 2023;65(1):e22353. doi: 10.1002/
dev.22353.
18. Eslami SM, Khorshidi L, Ghasemi M, Rashidian A, Mirghazanfari
M, Nezhadi A, et al. Protective effects of atorvastatin and
rosuvastatin on 3,4-methylenedioxymethamphetamine
(MDMA)-induced spatial learning and memory impairment.
Inflammopharmacology. 2021;29(6):1807-18. doi: 10.1007/
s10787-021-00891-y.
19. Saeedi Goraghani M, Ahmadi-Zeidabadi M, Bakhshaei S,
Shabani M, Ghotbi Ravandi S, Rezaei Zarchi S, et al. Behavioral
consequences of simultaneous postnatal exposure to MK-801
and static magnetic field in male Wistar rats. Neurosci Lett.
2019;701:77-83. doi: 10.1016/j.neulet.2019.02.026.
20. Huang Y, Jiang H, Zheng Q, Fok AHK, Li X, Lau CG, et
al. Environmental enrichment or selective activation of
parvalbumin-expressing interneurons ameliorates synaptic
and behavioral deficits in animal models with schizophrenialike behaviors during adolescence. Mol Psychiatry.
2021;26(6):2533-52. doi: 10.1038/s41380-020-01005-w.
21. Xu J, Li Y, Tian B, Liu H, Wu S, Wang W. The effects and
mechanism of environmental enrichment on MK-801
induced cognitive impairment in rodents with schizophrenia.
Front Cell Neurosci. 2022;16:1024649. doi: 10.3389/
fncel.2022.1024649.22. Wang Q, Wang MW, Sun YY, Hu XY, Geng PP, Shu H, et al.
Nicotine pretreatment alleviates MK-801-induced behavioral
and cognitive deficits in mice by regulating Pdlim5/CRTC1
in the PFC. Acta Pharmacol Sin. 2023;44(4):780-90. doi:
10.1038/s41401-022-00974-8.
23. Shu H, Wang M, Song M, Sun Y, Shen X, Zhang J, et al. Acute
nicotine treatment alleviates LPS-induced impairment of fear
memory reconsolidation through AMPK activation and CRTC1
upregulation in hippocampus. Int J Neuropsychopharmacol.
2020;23(10):687-99. doi: 10.1093/ijnp/pyaa043.
24. Hambsch B, Keyworth H, Lind J, Otte DM, Racz I, Kitchen I, et
al. Chronic nicotine improves short-term memory selectively
in a G72 mouse model of schizophrenia. Br J Pharmacol.
2014;171(7):1758-71. doi: 10.1111/bph.12578.
25. Martin LM, Sayette MA. A review of the effects of nicotine
on social functioning. Exp Clin Psychopharmacol.
2018;26(5):425-39. doi: 10.1037/pha0000208.
)